---
title: "mPEG-PSA Nanocarriers Enable Glucose‑Responsive Insulin Aspart Release in Diabetic Mice"
id: "pubmed-42927605"
canonical_url: "https://medichelpline.com/clinical-feed/pubmed-42927605"
content_type: "clinical_feed_article"
specialty: "Pharmacology"
source_name: "PubMed / NCBI"
source_url: "https://pubmed.ncbi.nlm.nih.gov/42927605/"
doi: "10.1021/acsabm.6c01204"
published_at: "2026-11-16T00:00:00.000Z"
evidence_level: "Journal Article"
license: "CC-BY-NC-4.0 / Informational Use"
---
# mPEG-PSA Nanocarriers Enable Glucose‑Responsive Insulin Aspart Release in Diabetic Mice
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/pubmed-42927605
- **Specialty:** [Pharmacology](https://medichelpline.com/clinical-feed/pharmacology.md)
- **Primary Source:** PubMed / NCBI
- **Source URL:** [Original Journal Publication](https://pubmed.ncbi.nlm.nih.gov/42927605/)
- **DOI:** [10.1021/acsabm.6c01204](https://doi.org/10.1021%2Facsabm.6c01204)
- **Published At:** 2026-11-16T00:00:00.000Z
- **Evidence Rating:** Journal Article
## Executive GIST (TL;DR)
- Investigators developed a glucose-sensitive insulin delivery system using **mPEG-PSA** copolymers synthesized from salicylic acid O-carboxyanhydride. - The team formed nanoparticles roughly 100–150 nm in diameter with favorable colloidal stability. Encapsulation efficiency approached ∼85% and drug loading was reported near ∼20%. - **Insulin aspart** bioactivity was preserved after formulation, according to the authors. - In vitro, release kinetics were glucose-dependent and could be tuned by varying the hydrophobicity of the PSA block; the source reported that release correlated with glucose levels. - The investigators tested the nanosystem in streptozotocin-induced diabetic mice, where IAsp@mPEG-PSA restored euglycemia within 0.5 hour and maintained normoglycemia for up to 10 hours without inducing hypoglycemia. - The nanosystem outperformed free IAsp and an mPEG-PLA formulation in the reported rodent model for combined postprandial and basal glycemic control. - The authors concluded mPEG-PSA is a promising polymeric candidate for **glucose-responsive insulin** delivery, but the source did not report clinical dosing, safety in humans, or regulatory milestones. - The published abstract did not present detailed methodology on dosing regimens, long-term toxicity studies, or steps toward translation to human trials; those remain unanswered in the report.
## Clinical Analysis & Structured Key Points
Clipboard, Search History, and several other advanced features are temporarily unavailable. [ Skip to main page content ](https://pubmed.ncbi.nlm.nih.gov/42927605/#article-details) ### NIH Websites Are Changing * [Get the Latest Updates and FAQs on the transition](https://www.nih.gov/web-modernization) * Per [Executive Order 14434](https://www.whitehouse.gov/presidential-actions/2026/09/inaugurating-the-era-of-super-intelligence/), federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition. ![U.S. flag](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png) An official website of the United States government Here's how you know ![Dot gov](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg) **The .gov means it’s official.** Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. ![Https](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg) **The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. [ ![NIH NLM Logo](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg) ](https://www.ncbi.nlm.nih.gov/) [Log in](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42927605%2F) Show account info Close #### Account Logged in as: **username** * [Dashboard](https://www.ncbi.nlm.nih.gov/myncbi/) * [Publications](https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/) * [Account settings](https://www.ncbi.nlm.nih.gov/account/settings/) * [Log out](https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A//pubmed.ncbi.nlm.nih.gov/42927605/) [Access keys](https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys) [NCBI Homepage](https://www.ncbi.nlm.nih.gov) [MyNCBI Homepage](https://pubmed.ncbi.nlm.nih.gov/myncbi/) [Main Content](https://pubmed.ncbi.nlm.nih.gov/42927605/#maincontent) [Main Navigation](https://pubmed.ncbi.nlm.nih.gov/42927605/) [ ![pubmed logo](https://cdn.ncbi.nlm.nih.gov/pubmed/a447896c-976f-490b-b86b-2668b65114a8/core/images/pubmed-logo-blue.svg) ](https://pubmed.ncbi.nlm.nih.gov/) [ ](https://pubmed.ncbi.nlm.nih.gov/42927605/ "Show search bar") Search: [](https://pubmed.ncbi.nlm.nih.gov/42927605/ "Clear search input")Search [Advanced](https://pubmed.ncbi.nlm.nih.gov/advanced/) [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/clipboard/) [ User Guide ](https://pubmed.ncbi.nlm.nih.gov/help/) Save Email Send to * [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/42927605/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42927605%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42927605%2F%23open-collections-panel) * [Citation manager](https://pubmed.ncbi.nlm.nih.gov/42927605/) Display options Display options Format Abstract PubMed PMID ## Save citation to file Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel ## Email citation Email address has not been verified. Go to [ My NCBI account settings ](https://account.ncbi.nlm.nih.gov/settings/) to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel ### Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42927605/) Add Cancel ### Add to My Bibliography * My Bibliography Unable to load your delegates due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42927605/) Add Cancel ## Your saved search Name of saved search: Search terms: [Test search terms](https://pubmed.ncbi.nlm.nih.gov/42927605/) Would you like email updates of new search results? Saved Search Alert Radio Buttons * Yes * No Email: ([change](https://www.ncbi.nlm.nih.gov/account/settings/)) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel ## Create a file for external citation management software Create file Cancel ## Your RSS Feed Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy ### Full text links [![Silverchair Information Systems full text link](https://cdn.ncbi.nlm.nih.gov/corehtml/query/egifs/https:--pubs.acs.org-ImageLibrary-acs_fulltext.png) Silverchair Information Systems ](https://pubs.acs.org/aabmcb/article-lookup/doi/10.1021/acsabm.6c01204 "See full text options at Silverchair Information Systems") [ Full text links ](https://pubmed.ncbi.nlm.nih.gov/42927605/) ### Actions Cite Collections Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42927605/) Add Cancel Permalink Permalink Copy Display options Display options Format Abstract PubMed PMID ### Experimental Resource Linked Discoveries ### Page navigation * [ Title & authors ](https://pubmed.ncbi.nlm.nih.gov/42927605/#heading) * [ Abstract ](https://pubmed.ncbi.nlm.nih.gov/42927605/#abstract) * [ MeSH terms ](https://pubmed.ncbi.nlm.nih.gov/42927605/#mesh-terms) * [ Substances ](https://pubmed.ncbi.nlm.nih.gov/42927605/#substances) * [Related information](https://pubmed.ncbi.nlm.nih.gov/42927605/#related-links) * [ Grants and funding ](https://pubmed.ncbi.nlm.nih.gov/42927605/#grants) * [ LinkOut - more resources ](https://pubmed.ncbi.nlm.nih.gov/42927605/#linkout) Title & authors Abstract MeSH terms Substances Related information Grants and funding LinkOut - more resources ACS Appl Bio Mater Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22ACS+Appl+Bio+Mater%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22ACS+Appl+Bio+Mater%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42927605/) . 2026 Nov 16;9(22):10641-10653. doi: 10.1021/acsabm.6c01204. # Nanocarriers for On-Demand Insulin Aspart Delivery: Integrated Control of Postprandial and Basal Glycemia in Type 2 Diabetic Mice [Hong Tang](https://pubmed.ncbi.nlm.nih.gov/?term=Tang+H&cauthor_id=42927605)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42927605/#full-view-affiliation-1 "State Key Laboratory of Chemical Resource Engineering, Beijing Key Laboratory of Bioprocess, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing100029, China."), [Ying Yang](https://pubmed.ncbi.nlm.nih.gov/?term=Yang+Y&cauthor_id=42927605)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42927605/#full-view-affiliation-2 "Department of Endocrinology, Xuanwu Hospital, Capital medical university, Beijing100053, China."), [Pu Meng](https://pubmed.ncbi.nlm.nih.gov/?term=Meng+P&cauthor_id=42927605)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42927605/#full-view-affiliation-1 "State Key Laboratory of Chemical Resource Engineering, Beijing Key Laboratory of Bioprocess, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing100029, China."), [Xinyu Li](https://pubmed.ncbi.nlm.nih.gov/?term=Li+X&cauthor_id=42927605)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42927605/#full-view-affiliation-1 "State Key Laboratory of Chemical Resource Engineering, Beijing Key Laboratory of Bioprocess, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing100029, China."), [Junjiao Yang](https://pubmed.ncbi.nlm.nih.gov/?term=Yang+J&cauthor_id=42927605)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42927605/#full-view-affiliation-3 "College of Chemistry, Beijing University of Chemical Technology, Beijing100029, China."), [Bo Zhang](https://pubmed.ncbi.nlm.nih.gov/?term=Zhang+B&cauthor_id=42927605)[ 4 ](https://pubmed.ncbi.nlm.nih.gov/42927605/#full-view-affiliation-4 "Department of Endocrinology, China-Japan Friendship Hospital, Beijing100029, China."), [Jing Yang](https://pubmed.ncbi.nlm.nih.gov/?term=Yang+J&cauthor_id=42927605)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42927605/#full-view-affiliation-1 "State Key Laboratory of Chemical Resource Engineering, Beijing Key Laboratory of Bioprocess, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing100029, China.") Affiliations Expand ### Affiliations * 1 State Key Laboratory of Chemical Resource Engineering, Beijing Key Laboratory of Bioprocess, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing100029, China. * 2 Department of Endocrinology, Xuanwu Hospital, Capital medical university, Beijing100053, China. * 3 College of Chemistry, Beijing University of Chemical Technology, Beijing100029, China. * 4 Department of Endocrinology, China-Japan Friendship Hospital, Beijing100029, China. * PMID: **42927605** * DOI: [ 10.1021/acsabm.6c01204 ](https://doi.org/10.1021/acsabm.6c01204) Item in Clipboard # Nanocarriers for On-Demand Insulin Aspart Delivery: Integrated Control of Postprandial and Basal Glycemia in Type 2 Diabetic Mice Hong Tang et al. ACS Appl Bio Mater. 2026. Show details Display options Display options Format Abstract PubMed PMID ACS Appl Bio Mater Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22ACS+Appl+Bio+Mater%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22ACS+Appl+Bio+Mater%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42927605/) . 2026 Nov 16;9(22):10641-10653. doi: 10.1021/acsabm.6c01204. ### Authors [Hong Tang](https://pubmed.ncbi.nlm.nih.gov/?term=Tang+H&cauthor_id=42927605)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42927605/#short-view-affiliation-1 "State Key Laboratory of Chemical Resource Engineering, Beijing Key Laboratory of Bioprocess, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing100029, China."), [Ying Yang](https://pubmed.ncbi.nlm.nih.gov/?term=Yang+Y&cauthor_id=42927605)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42927605/#short-view-affiliation-2 "Department of Endocrinology, Xuanwu Hospital, Capital medical university, Beijing100053, China."), [Pu Meng](https://pubmed.ncbi.nlm.nih.gov/?term=Meng+P&cauthor_id=42927605)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42927605/#short-view-affiliation-1 "State Key Laboratory of Chemical Resource Engineering, Beijing Key Laboratory of Bioprocess, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing100029, China."), [Xinyu Li](https://pubmed.ncbi.nlm.nih.gov/?term=Li+X&cauthor_id=42927605)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42927605/#short-view-affiliation-1 "State Key Laboratory of Chemical Resource Engineering, Beijing Key Laboratory of Bioprocess, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing100029, China."), [Junjiao Yang](https://pubmed.ncbi.nlm.nih.gov/?term=Yang+J&cauthor_id=42927605)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42927605/#short-view-affiliation-3 "College of Chemistry, Beijing University of Chemical Technology, Beijing100029, China."), [Bo Zhang](https://pubmed.ncbi.nlm.nih.gov/?term=Zhang+B&cauthor_id=42927605)[ 4 ](https://pubmed.ncbi.nlm.nih.gov/42927605/#short-view-affiliation-4 "Department of Endocrinology, China-Japan Friendship Hospital, Beijing100029, China."), [Jing Yang](https://pubmed.ncbi.nlm.nih.gov/?term=Yang+J&cauthor_id=42927605)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42927605/#short-view-affiliation-1 "State Key Laboratory of Chemical Resource Engineering, Beijing Key Laboratory of Bioprocess, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing100029, China.") ### Affiliations * 1 State Key Laboratory of Chemical Resource Engineering, Beijing Key Laboratory of Bioprocess, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing100029, China. * 2 Department of Endocrinology, Xuanwu Hospital, Capital medical university, Beijing100053, China. * 3 College of Chemistry, Beijing University of Chemical Technology, Beijing100029, China. * 4 Department of Endocrinology, China-Japan Friendship Hospital, Beijing100029, China. * PMID: **42927605** * DOI: [ 10.1021/acsabm.6c01204 ](https://doi.org/10.1021/acsabm.6c01204) Item in Clipboard Full text links Cite Display options Display options Format Abstract PubMed PMID Linked Discoveries ## Abstract Type 2 diabetes mellitus demands coordinated control of fasting and postprandial glycemia, and current clinical rapid-acting insulin aspart (IAsp) suffers from short action duration and hypoglycemia-related risks. We describe a glucose-sensitive insulin delivery system based on rigid amphiphilic methoxy poly(ethylene glycol)-polysalicylate (mPEG-PSA) copolymers synthesized by controlled ring-opening polymerization of salicylic acid O-carboxyanhydride, with a structure substantially different from conventional aliphatic polyesters. The 100-150 nm nanoparticles possessed favorable colloidal stability, ∼85% encapsulation efficiency and ∼20% drug loading, and IAsp bioactivity was well preserved. In vitro release followed glucose-dependent kinetics tuned by PSA hydrophobicity. In streptozotocin-induced diabetic mice, IAsp@mPEG-PSA restored euglycemia within 0.5 h and maintained normoglycemia for up to 10 h without hypoglycemia, outperforming free IAsp and mPEG-PLA formulations in this animal model. The nanosystem realized glucose-activated on-demand insulin release to suppress repeated glucose spikes, accomplishing combined postprandial and basal glycemic regulation in rodents. This study presents mPEG-PSA as a promising polymeric candidate for glucose-responsive insulin delivery. **Keywords:** diabetes; insulin delivery; nanocarriers; postprandial glycemia; regulated release. © 2026 American Chemical Society. [PubMed Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) ## MeSH terms * Animals Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Animals%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Animals) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42927605/) * Biocompatible Materials* / chemical synthesis Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Biocompatible+Materials%2Fchemical+synthesis%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Biocompatible+Materials) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42927605/) * Biocompatible Materials* / chemistry Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Biocompatible+Materials%2Fchemistry%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Biocompatible+Materials) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42927605/) * Blood Glucose / drug effects Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Blood+Glucose%2Fdrug+effects%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Blood+Glucose) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42927605/) * Diabetes Mellitus, Experimental* / chemically induced Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Diabetes+Mellitus%2C+Experimental%2Fchemically+induced%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Diabetes+Mellitus%2C+Experimental) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42927605/) * Diabetes Mellitus, Experimental* / drug therapy Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Diabetes+Mellitus%2C+Experimental%2Fdrug+therapy%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Diabetes+Mellitus%2C+Experimental) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42927605/) * Diabetes Mellitus, Type 2* / drug therapy Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Diabetes+Mellitus%2C+Type+2%2Fdrug+therapy%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Diabetes+Mellitus%2C+Type+2) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42927605/) * Drug Carriers* / chemistry Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Drug+Carriers%2Fchemistry%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Drug+Carriers) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42927605/) * Hypoglycemic Agents* / administration & dosage Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Hypoglycemic+Agents%2Fadministration+and+dosage%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Hypoglycemic+Agents) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42927605/) * Hypoglycemic Agents* / chemistry Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Hypoglycemic+Agents%2Fchemistry%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Hypoglycemic+Agents) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42927605/) * Insulin Aspart* / administration & dosage Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Insulin+Aspart%2Fadministration+and+dosage%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Insulin+Aspart) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42927605/) * Insulin Aspart* / chemistry Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Insulin+Aspart%2Fchemistry%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Insulin+Aspart) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42927605/) * Insulin Aspart* / pharmacology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Insulin+Aspart%2Fpharmacology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Insulin+Aspart) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42927605/) * Insulin Aspart* / therapeutic use Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Insulin+Aspart%2Ftherapeutic+use%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Insulin+Aspart) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42927605/) * Male Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Male%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Male)
## Related Clinical Research

- [V-type Starch–Lycopene Complex Improves Glycemia and Glycogen Stability in db/db Mice via Gut Micr](https://medichelpline.com/clinical-feed/pubmed-42907031.md) (DOI: 10.1016/j.carbpol.2026.125905)
- [Macrophage HDAC3 and GDF3 Drive Adipose Inflammation and Metabolic Dysfunction](https://medichelpline.com/clinical-feed/pubmed-42731468.md) (DOI: 10.1016/j.intimp.2026.117385)
- [Metformin reduces metabolic and oxidative changes in a high-sucrose Drosophila model](https://medichelpline.com/clinical-feed/plos-one-13-metformin-modulates-survival-oxidative-stress-and-gene-expression-in-a-high.md)
- [Amylyx Presents Avexitide Results; MiniMed Launches Tubeless Insulin Pump](https://medichelpline.com/clinical-feed/endocrine-news-0-pharma-friday-november-21-2026.md)
- [U.S. POINTER: Structured lifestyle program slows brain aging and cardiometabolic risk over 24 mont](https://medichelpline.com/clinical-feed/medical-news-today-0-combining-physical-mental-and-social-habits-slows-brain-aging-in-2-year-trial.md)

## Navigation
- [← Back to Pharmacology Feed](https://medichelpline.com/clinical-feed/pharmacology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.